Skip to main content
. 2014 Feb 4;55(2):737–744. doi: 10.1167/iovs.13-13429

Figure 3.

Figure 3

Vascular endothelial growth factor-A.shRNA versus anti-VEGF treatments on retinal vascular morphology. Images of lectin-stained retinal flat mounts from pups treated with luc.shRNA, VEGFA.shRNA, IgG, and anti-VEGF at p18 in the ROP model.